Con­tract man­u­fac­tur­er: FDA has halt­ed do­mes­tic phar­ma in­spec­tions

The FDA ap­pears to have halt­ed its do­mes­tic in­spec­tions of phar­ma­ceu­ti­cal fa­cil­i­ties, al­though not be­fore at­tempt­ing to in­spect a con­tract de­vel­op­ment and man­u­fac­tur­ing or­ga­ni­za­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER